Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

Benzer Materyaller

• Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference
  Yazar:: Alma, Harma, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Thresholds for clinically important deterioration versus improvement in COPD health status: results from a randomised controlled trial in pulmonary rehabilitation and an observational study during routine clinical practice
  Yazar:: Alma, Harma Johanna, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
  Yazar:: van der Molen, Thys, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• COPD management: role of symptom assessment in routine clinical practice
  Yazar:: van der Molen, Thys, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Putting health status guided COPD management to the test: protocol of the MARCH study
  Yazar:: Kocks, Janwillem, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)